Vermont Statutes
Chapter 84 - Possession and Control of Regulated Drugs
§ 4215b. Identification

§ 4215b. Identification
Only a patient for whom a prescription was written, the owner of an animal for which a prescription was written, or a bona fide representative of the patient or animal owner, as defined by the Board of Pharmacy by rule after consultation with the Commissioner of Health, may pick up a prescription for a Schedule II, III, or IV controlled substance. Prior to dispensing a prescription for a Schedule II, III, or IV controlled substance to a patient not personally known to the pharmacist, the pharmacist shall require the individual receiving the drug to provide a signature and show valid and current government-issued photographic identification as evidence that the individual is the patient for whom the prescription was written, the owner of the animal for which the prescription was written, or the bona fide representative of the patient or animal owner. If the individual does not have valid, current government-issued photographic identification, the pharmacist may request alternative evidence of the individual’s identity, as appropriate. (Added 2013, No. 75, § 3; amended 2013, No. 138 (Adj. Sess.), § 10.)

Structure Vermont Statutes

Vermont Statutes

Title 18 - Health

Chapter 84 - Possession and Control of Regulated Drugs

§ 4201. Definitions

§ 4202. Powers and duties of the Board of Health

§ 4203. Persons exempted

§ 4204. Preparations excepted

§ 4205. Acts prohibited

§ 4206. Licenses

§ 4207. Certificates of approval

§ 4208. Qualifications for issuance of licenses and certificates

§ 4209. Supervision, revocation, and reinstatement of licenses and certificates

§ 4210. Authorized sales on written orders, records

§ 4211. Records confidential

§ 4212. Labels

§ 4213. Authorized sales of regulated drugs

§ 4214. Authorized professional use of regulated drugs

§ 4215. Authorized sales by pharmacists

§ 4215a. Sale of schedule V drugs

§ 4215b. Identification

§ 4216. Authorized possession by individuals

§ 4217. Reports by physicians and hospitals

§ 4218. Enforcement

§ 4220. Violations; proceedings

§ 4221. Violations; presumptions

§ 4222. Common nuisances

§ 4223. Fraud or deceit

§ 4224. Unused Prescription Drug Disposal Program

§ 4226. Minors; treatment; consent

§ 4228. Unlawful manufacture, distribution, dispensing, or sale of a noncontrolled drug or substance

§ 4229. Maintenance of records

§ 4230. Cannabis

§ 4230a. Cannabis possession by a person 21 years of age or older

§ 4230b. Cannabis possession by a person 16 years of age or older and under 21 years of age; civil violation

§ 4230e. Cultivation of cannabis by a person 21 years of age or older

§ 4230f. Dispensing cannabis to a person under 21 years of age; criminal offense

§ 4230g. Dispensing cannabis to a person under 21 years of age; civil action for damages

§ 4230h. Chemical extraction via butane or hexane prohibited

§ 4230i. Exceptions

§ 4230j. Cannabis possession by a person under 16 years of age; delinquency

§ 4231. Cocaine

§ 4232. LSD

§ 4233. Heroin

§ 4233a. Fentanyl

§ 4234. Depressant, stimulant, and narcotic drugs

§ 4234a. Methamphetamine

§ 4234b. Ephedrine and pseudoephedrine

§ 4235. Hallucinogenic drugs

§ 4235a. Ecstasy

§ 4236. Manufacture or cultivation

§ 4237. Selling or dispensing to minors; selling on school grounds

§ 4238. Second and subsequent offenses

§ 4239. Collection of fines

§ 4240. Prevention and treatment of opioid-related overdoses

§ 4241. Scope

§ 4242. Seizure

§ 4243. Judicial forfeiture procedure

§ 4244. Forfeiture hearing

§ 4245. Remission or mitigation of forfeiture

§ 4246. Maintenance

§ 4247. Disposition of property

§ 4248. Records

§ 4249. Transportation of alcohol, tobacco, or regulated drugs into places of detention

§ 4250. Selling or dispensing a regulated drug with death resulting

§ 4252. Penalties for dispensing or selling regulated drugs in a dwelling

§ 4253. Use of a firearm while selling or dispensing a drug

§ 4254. Immunity from liability

§ 4255. Vermont Prescription Drug Advisory Council